@1ibfisherman
Stumbled upon a fascinating read. Two key takeaways:
1. Anti-obesity drug sales are skyrocketing, shooting up from ₹137 crore in 2020 to an anticipated ₹535 crore in 2025.
2. A staggering 80 million Indians are dealing with obesity, and 30 million face related health issues. Eye-opening stuff!